Amin Arti Chopra DPM is categorized under Internal Medicine Doctors in Corona, CA and active since 2007.
Amin Arti Chopra DPM was established in 2007, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6213910 by the NAICS.
If you are seeking more information, feel free to contact Arti Chopra Amin at the company’s single location by writing to 800 Magnolia Avenue # 118, Corona, California CA 92879 or by phoning (714) 974-3338. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Amin Arti Chopra DPM |
Contact Person: | Arti Chopra Amin |
Address: | 800 Magnolia Avenue # 118, Corona, California 92879 |
Phone Number: | (714) 974-3338 |
Website Address: | katzpodiatry.com |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2007 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Internal Medicine Doctors |
SIC Code: | 8011 |
NAICS Code: | 6213910 |
Share This Business: |
Amin Arti Chopra DPM was started in 2007 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6213910. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Arti Chopra Amin for inquiries that concern Amin Arti Chopra DPM by calling the company number (714) 974-3338, as your correspondence is most welcome. Additionally, the physical location of the single location of Amin Arti Chopra DPM can be found at the coordinates 33.85947,-117.55322 as well as the street address 800 Magnolia Avenue # 118 in Corona, California 92879.
For its online presence, you may visit Amin Arti Chopra DPM’s website at katzpodiatry.com and engage with its social media outlets through on Twitter and on Facebook.